<DOC>
	<DOCNO>NCT01913327</DOCNO>
	<brief_summary>The purpose study determine whether two commonly-prescribed antipsychotic medication ( aripiprazole risperidone ) different effect brain function cognition schizophrenia patient .</brief_summary>
	<brief_title>Antipsychotic Effects Brain Function Schizophrenia</brief_title>
	<detailed_description>Patients schizophrenia significant problem think , refer cognitive dysfunction , make difficult function well , effective treatment time . A number exist medication currently use medical psychiatric condition consider , however , none yet show unequivocal sign effectiveness problem schizophrenia . One important reason , properly test , antipsychotic treatment may affect impact new medication cognition . In present study , investigator evaluate two different antipsychotic medication may different impact brain process give rise important cognitive function impair schizophrenia . They conduct functional MRI schizophrenia patient perform cognitive task , 8 week treatment either aripiprazole risperidone . Then investigator evaluate effect new medication call modafinil , may improve brain cognitive function , depend antipsychotic medication patient take . The result study may inform researcher , doctor patient understand effect drug brain cognition , treatment might best improve cognition schizophrenia , order improve patient ' ability function live . 40 right-handed adult schizophrenia significant medical neurological illness ( 18-30 year old ) 1 ) undergo fMRI performance cognitive control task , 2 ) randomize 8-week , double-blind antipsychotic treatment trial , follow 3 ) repeat fMRI single-dose , counterbalance study Modafinil ( one 200 milligram oral add-on dose ) v . Placebo ( Placebo ) . Neuroimaging measure primary endpoint , cognition secondary , symptoms exploratory endpoint . Diagnoses make SCID-I DSM-IV-TR criterion , PhD MD clinician ( demonstrated reliability ) , follow consensus . A research pharmacist randomly assign treatment ( without stratification ) , package ARI RIS identical-appearing capsule . A blinded clinician measure symptom within 3 day antipsychotic initiation weekly thereafter ; adjust dos base weekly evaluation symptom side effect , evaluate treatment adherence substance use . The diagnostician , pharmacist treat psychiatrist otherwise uninvolved study . Low-dose benztropine ( ≤2 mg daily ) , lorazepam ( ≤1 mg daily ) antidepressant treatment permit , adrenergic agent anticonvulsant . Initiation , step , maximal antipsychotic dos respectively : ARI ( 7.5 , 7.5 30 mg , daily ) ; RIS ( 2 , 2 8 mg daily ) . If patient tolerate treatment ( minimal dose ) , exhibit treatment-refractory symptom ( high tolerate dose ) , discontinue study , blind broken , transition naturalistic treatment clinic . Receptor antagonist load ( daily dose X Haldol equivalent ) compute patient unblinding , use index α2 α1 receptor , D2 muscarinic receptor . In last half 8th week antipsychotic treatment , subject undergo fMRI two day , separate one day modafinil washout . They receive modafinil ( 200 mg po ) one day Placebo ( double-blind , counterbalance ) , mid-morning , scan 3-4 hour later , average peak plasma level modafinil 30 . All subject provide inform consent procedure , approve UCSF IRB . This study meet CONSORT standard clinical trial design , conduct reporting . functional MRI . 3 Tesla Siemens Timm Trio 8 channel coil use event-related fMRI , single-shot , T2*-weighted sequence , ( TR 2000 m , TE 30 m , flip angle 90° , FOV 220 x 220 mm , 36 contiguous axial oblique slice , 3.4 mm isotropic voxels ) . A structural MRI ( MP-RAGE ) acquire normalization EPI image . Pre-processing include spatial realignment , slice timing correction , spatial normalization T1 template , 8mm smoothing kernel . The GLM use HRF convolve series delta function , regressors Task event , combination Modafinil Placebo either Cue Target . Errors/no-response trial model separately . The functional connectivity analysis use LC-seeded beta series method ; event model uniquely time series beta ( segregate task/treatment condition ) correlate seed every voxel . The LC localize EPI image mask MNI space , derive voxels meet criterion : A ) locate rostrodorsal pons , adjacent 4th ventricle/sylvian aqueduct , restrict anatomically-defined dorsal pontine mask ( e.g. , extend rostrally mesencephalon superiorly 4th ventricle ; B ) show significant association in-scanner pupil diameter , use parametric regressor GLM BOLD time series , independent , healthy sample without treatment . Specific Aim 1 . To test whether aripiprazole preserve LC , PFC cognitive control function great degree risperidone schizophrenia outpatient . Hypothesis 1 . ARI group exhibit great task-related PFC activity LC-PFC connectivity RIS group , 8 week antipsychotic treatment : ( post-antipsychotic Placebo ) vs. ( pre-antipsychotic Baseline ) . Specific Aim 2A . To test whether aripiprazole superior risperidone permit modafinil enhancement LC PFC activity cognition . Hypothesis 2A . The ARI group , vs. RIS group , exhibit 2A ) great effect Modafinil ( v . Placebo ) task-related LC activity great cognitive control task improvement . Specific Aim 2B . To test role α2 autoreceptor antagonism antipsychotic medication source blunt LC response Modafinil . Hypothesis 2B . Across group ( ARI+RIS ) , α2 autoreceptor antagonist load correlate impair Modafinil effect ( v . Placebo ) task-related LC activity cognitive control performance . These aim relate interdependent : antipsychotic effect LC/PFC/cognitive function , vs. antipsychotic effect moderate modafinil action measure , represent distinct research question . Hypothesis 1 test contrast indicated per Aim 1 Prediction table . This analogous directional test Group-by-Time-by-Task interaction . Hypothesis 2A test per Aim 2 Prediction table . We predict ARI treatment support great task-related Modafinil effect LC activity , vs. RIS treatment . Hypothesis 2B test across patient correlate α2 load ( antipsychotic ) mean task-related LC beta Treatment X Task Condition contrast . Significance analyse set p &lt; .05 , FDR-corrected , use LC SVC , appropriate . Accuracy RT cost test ANOVA .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>less 40 year old ; currently meet criterion schizophrenia , schizophreniform disorder schizoaffective disorder DSMIVTR ; require new change treatment antipsychotic medication . old 40 year ; current antipsychotic treatment satisfactory ; treatmentrefractory psychosis ; active substancerelated disorder ; clinicallyunstable ( e.g . acute symptom require emergent acutecare , include acute suicide risk ) ; neurological illness poorlycontrolled medical illness ; currently take medication serious medical illness significant interaction modafinil ; active pregnancy ; intelligence le 70 ( standard test ) ; contraindication fMRI ( e.g . claustrophobia , metal foreign body , etc . ) ; uncorrectable visual acuity impairment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>cognition</keyword>
	<keyword>executive function</keyword>
	<keyword>prefrontal cortex</keyword>
	<keyword>locus coeruleus</keyword>
</DOC>